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Clozapine modiﬁes the differentiation program of human
adipocytes inducing browning
E Kristóf1, Q-M Doan-Xuan2, AK Sárvári1, Á Klusóczki1, P Fischer-Posovszky3, M Wabitsch3, Z Bacso2, P Bai4,5,6, Z Balajthy1 and L Fésüs1,7
Administration of second-generation antipsychotic drugs (SGAs) often leads to weight gain and consequent cardio-metabolic side
effects. We observed that clozapine but not six other antipsychotic drugs reprogrammed the gene expression pattern of
differentiating human adipocytes ex vivo, leading to an elevated expression of the browning marker gene UCP1, more and smaller
lipid droplets and more mitochondrial DNA than in the untreated white adipocytes. Laser scanning cytometry showed that up to
40% of the differentiating single primary and Simpson–Golabi–Behmel syndrome (SGBS) adipocytes had the characteristic
morphological features of browning cells. Furthermore, clozapine signiﬁcantly upregulated ELOVL3, CIDEA, CYC1, PGC1A and TBX1
genes but not ZIC1 suggesting induction of the beige-like and not the classical brown phenotype. When we tested whether
browning induced by clozapine can be explained by its known pharmacological effect of antagonizing serotonin (5HT) receptors, it
was found that browning cells expressed 5HT receptors 2A, 1D, 7 and the upregulation of browning markers was diminished in the
presence of exogenous 5HT. Undifferentiated progenitors or completely differentiated beige or white adipocytes did not respond
to clozapine administration. The clozapine-induced beige cells displayed increased basal and oligomycin-inhibited (proton leak)
oxygen consumption, but these cells showed a lower response to cAMP stimulus as compared with control beige adipocytes
indicating that they are less capable to respond to natural thermogenic anti-obesity cues. Our data altogether suggest that novel
pharmacological stimulation of these masked beige adipocytes can be a future therapeutic target for the treatment of SGA-induced
weight gain.
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INTRODUCTION
Obesity is one of the major risk factors of metabolic syndrome,
coronary heart disease and cancer, which are leading causes of
morbidity and mortality today.1,2 Recent studies showed high
incidence of metabolically active brown adipose tissue (BAT),
which can dissipate energy directly into heat in healthy adult
humans and revealed the strong negative correlation between
obesity and the amount of BAT.3–5 Energy expenditure of BAT is
not exclusively mediated by the ab ovo-differentiated classical
brown adipocytes.6 Beige cells that can be found interspersed in
subcutaneous white adipose tissue (WAT) and generated in a
process called ‘browning’ also has a signiﬁcant role.7–9 Although
several studies suggest that a large proportion of the thermogenic
fat depots in adult humans is mostly composed of beige cells,
there is only limited information about the origin of beige
adipocytes and the regulators of beige adipogenesis in
humans.10–12 The available data obtained from mouse models
and human samples suggest that the differentiation of beige cells,
characterized by the elevated expression of the beige-selective
TBX1 gene,10 is mostly induced from a distinct precursor as a result
of several stimuli (for example, cold, physical exercise, diet) at least
partially regulated by the β-adrenergic signaling pathway.13,14
Beige adipocyte development can be highly enhanced by several
neuro-endocrine or paracrine factors (for example, norepinephr-
ine, irisin, atrial natriuretic peptide, bone morphogenic protein-7),
which determine a beige potential or thermogenic competency of
each individual.15–17 When the thermogenic stimulus subsides,
‘masked’ beige cells persist that they, however, have a white
adipocyte-like morphology in vivo.14,18 Both ‘mature’ and ‘masked’
beige adipocytes are able to activate UCP1 expression and their
thermogenic capacity in response to a recurring β-adrenergic
stimulus.10,14,18 Thus, the augmentation of beige potential or the
identiﬁcation and subsequent thermogenic induction of ‘masked’
beige adipocytes, for example, by stimulating the β3-adrenergic
pathway can be a future therapeutic target against obesity and
type 2 diabetes mellitus.19,20
The prevalence rate of obesity and its comorbidities is at least
two times higher in patients suffering from schizophrenia or other
severe mental illnesses compared with the general
population.21,22 Moreover, the long-term administration of
second-generation antipsychotic drugs (SGAs), especially cloza-
pine, olanzapine, risperidone and quetiapine further increases the
incidence of weight gain and metabolic syndrome in patients with
severe mental illnesses.23–25 Different mechanisms were pro-
posed, which might underlie the SGA-induced weight gain.26
These include the increase of appetite related to the activation of
hypothalamic AMP kinase via histamine H1 receptors in rodents,27
decrease of insulin sensitivity in rats,28 defects in insulin secretion
or clearance in dogs29 or rats,30 altered gut microbiota in rats31
and humans,32 induced low-grade inﬂammation in the adipose
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tissue in rats33,34 and humans35 and direct stimulation of
adipogenesis in rodents.36,37
Previously, we demonstrated that the long-term SGA adminis-
tration enhanced the expression of several white and general
adipogenic marker genes and pro-inﬂammatory mediators in
differentiating human adipocytes.35 Surprisingly, we also observed
that the treatment with clozapine but not with other antipsychotic
drugs resulted in the elevated expression of the major brown and
beige adipocyte marker gene, UCP1. Using gene expression
measurements, functional analysis of mitochondrial respiration
and the recently developed laser scanning cytometry (LSC)-based
technique, which could clearly discriminate between the white
and brown adipocytes in cell culture conditions,38 we found that
clozapine modiﬁed the differentiation program of human
adipocyte precursors, presumably via the inhibition of serotonin
(5HT) receptor-mediated signaling, leading to the generation of
beige adipocytes with masked and not fully responsive thermo-
genic potential.
MATERIALS AND METHODS
Materials
All the chemicals were from Sigma-Aldrich (Munich, Germany) unless
stated otherwise.
Ethics statement
Human adipose-derived mesenchymal stem cells (hADMSCs) were isolated
from subcutaneous abdominal adipose tissue of healthy volunteers (body
mass index o29.9) aged 20–65 years who underwent a planned surgical
treatment (herniotomy). Written informed consent from all the participants
was obtained before the surgical procedure. The study protocol was
approved by the Ethics Committee of the University of Debrecen, Hungary
(No. 3186-2010/DEOEC RKEB/IKEB). All the experiments were carried out in
accordance with the approved ethical guidelines and regulations.
Isolation of hADMSCs, cell culture, ex vivo differentiation induction
and treatments
The hADMSCs were isolated and cultivated from the stromal-vascular
fraction (SVF) of abdominal subcutaneous fat as described previously.35,38
White35,38–40 and positive control beige adipocytes38,41,42 were differen-
tiated from the hADMSCs, or from the Simpson–Golabi–Behmel syndrome
(SGBS) preadipocyte cell line39,40 (University Medical Center Ulm, Ulm,
Germany) according to the already described protocols. The absence of
mycoplasma was checked by polymerase chain reaction (PCR) analysis
(PCR Mycoplasma Test Kit I/C, PromoKine, PromoCell France). The
antipsychotic drugs were dissolved in dimethyl sulfoxide and differentiat-
ing adipocytes were treated every day in the following ﬁnal concentra-
tions: olanzapine 50 ng ml− 1, ziprasidone 50 ng ml− 1, quetiapine
50 ng ml− 1, aripiprazole 100 ng ml− 1, haloperidol 10 ng ml− 1 and risper-
idone 50 ng ml− 1.35 Clozapine was administered at 100 ng ml− 1 concen-
tration to the hADMSCs and to the fully differentiated white or brown
adipocytes for 12 h (short-term treatment) or on the last 2 and 4 days or
during the whole white adipogenic differentiation process (long-term
treatment). Where indicated, the cells were treated with 5HT at 10 μM
concentration during the whole adipocyte differentiation.43 To investigate
the response of differentiated adipocytes to thermogenic induction, the
cells received a single bolus of dibutyril-cAMP at 500 μM concentration for
4 h.6
RNA and DNA preparation, PCR array and TaqMan real-time PCR
The messenger RNA (mRNA) expressions in response to the treatment with
the seven antipsychotic drugs were determined with CAPH09329 Custom
Human RT2 Proﬁler PCR Arrays (SABiosciences, Frederick, MD, USA) as
described previously.35 See reference 38 for details about TaqMan Real-
time PCR. Mitochondrial DNA quantiﬁcation by Quantitative PCR was
carried out as described previously.38 Quantitative PCR experiments were
repeated at least ﬁve times with SVFs from independent healthy donors or
with SGBS samples from independent passages.
Immunoﬂuorescence staining, image acquisition and
quantiﬁcation of ex vivo brown adipocyte differentiation
The hADMSCs or SGBS cells were plated on Ibidi eight-well microslides and
differentiated as previously described. Vital and immunoﬂuorescence
stainings were carried out as described previously.38 First- and second-
sample scanning was done by iCys Research Imaging Cytometer (iCys,
Thorlabs Imaging Systems, Sterling, VA, USA). The images were processed
and analyzed (n= 3, 2000 cells per donor or SGBS sample) by our high-
throughput automatic cell-recognition protocol using the iCys companion
software (iNovator Application Development Toolkit, CompuCyte Corpora-
tion, Westwood, MA, USA) and CellProﬁler (The Broad Institute of MIT, MA,
USA). See reference ref. 38 for further details about the analysis.
Immunoblotting
The polyvinylidene ﬂuoride membranes were probed by polyclonal anti-
Ucp1 (U6382) and monoclonal anti-Gapdh (Millipore, Billerica, MA, USA,
MAB374) antibodies overnight at 4 °C, followed by incubation with
horseradish-peroxidase-conjugated species-corresponding secondary anti-
bodies (Covalab, Villeurbanne, France, lab0252 and lab0273) for 1 h at
room temperature. Densitometry was carried out using Image J software
(n= 3). See reference ref. 38 for a more detailed description.
Oxygen consumption
Oxygen consumption was measured using an XF96 oxymeter (Seahorse
Biosciences, North Billerica, MA, USA). The hADMSCs were seeded and
differentiated in 96-well XF96 assay plates. After recording the baseline OC,
the cells received a single bolus of dibutyril-cAMP at 500 μM concentration
modeling adrenergic stimulation. Then, stimulated OC was recorded every
30 min. The ﬁnal reading took place at 5 h post treatment. To exclude that
dibutyril-cAMP enhanced lipolysis might provoke artefactual mitochondrial
uncoupling, we repeated the OC measurements including 2% BSA in the
respiration buffer.44 The adipocytes were treated with 5 μM etomoxir or
with 2 mM β-guanidinopropionic acid to block beta-oxidation and creatine-
driven substrate cycle.45 Next, proton leak respiration was determined after
adding oligomycin at 2 μM concentration to block ATP synthase activity. As
a last step, the cells received a single bolus of Antimycin A at 10 μM
concentration for baseline correction. The oxygen consumption rate (OCR)
was normalized to protein content and normalized readings were
displayed. For statistical analysis (n= 4), the fold change of OC levels were
calculated comparing the basal, cAMP-stimulated and oligomycin-
inhibited (both in unstimulated and stimulated cells) OCRs of each sample
to the basal OCR of untreated white adipocytes.38,42,46
Statistical analysis
The results are expressed as the mean± s.d. for the number of assays
indicated. The sample sizes were chosen to ensure adequate statistical
power following the practice of similar studies.35,38,40,42 The normality of
distribution of the data was tested by Kolmogorov–Smirnov test. For
multiple comparisons of groups, statistical signiﬁcance was calculated and
evaluated by one-way analysis of variance followed by Tukey post hoc test.
In comparison of two groups, two-tailed Student’s t-test was used. The
data were analyzed using Prism 6.01 (GraphPad Software, San Diego,
CA, USA).
RESULTS
Long-term clozapine treatment induces a beige-like gene
expression pattern in differentiating adipocytes
The hADMSCs were cultivated from the SVF of abdominal
subcutaneous fat35,38 and a previously described differentiation
protocol was applied to induce white adipocyte differen-
tiation.35,39 Using this ex vivo approach, up to 50% of the treated
hADMSCs were able to accumulate large lipid droplets, which
could be quantiﬁed by LSC in a time-dependent manner.40
Primarily, we aimed to investigate the direct effect of seven
antipsychotic drugs at doses comparable to their therapeutic
plasma concentrations35,47–50 on the gene expression of the
differentiating adipocytes. After a 14 days long white adipogenic
differentiation39 and parallel daily administration of antipsycho-
tics, whole cell lysates were collected, then mRNA expressions
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Figure 1. Relative expression of brown and beige adipogenic markers and key transcriptional regulators of brown adipocyte development in
primary human adipocytes as a result of clozapine treatment during ex vivo white or beige adipocyte differentiation. SVF-derived hADMSCs
were differentiated for 2 weeks to white (W) or positive control beige (Be) adipocytes. Clozapine (gray bars) was administered at 100 ng ml− 1
concentration on the last 2 and 4 days or during the whole white adipogenic differentiation process. The experiment was repeated six times
with SVFs from independent healthy donors (Relative gene expression was determined by RT-qPCR, target genes were normalized to GAPDH);
*Po0.05, **Po0.01. hADMSC, human adipose-derived mesenchymal stem cell; RT-qPCR, quantitative PCR with reverse transcription; SVF,
stromal-vascular fraction.
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were determined by a custom PCR Array.35 We found that
clozapine administration resulted in a sixfold upregulation of
UCP1, the major brown and beige adipocyte marker gene.51 None
of the used other ﬁve SGAs (olanzapine, ziprasidone, quetiapine,
aripiprazole and risperidone) and a typical antipsychotic (haloper-
idol) inﬂuenced the expression of UCP1 (Supplementary Figure 1).
As a next step, we intended to validate the aforementioned
effect of clozapine by TaqMan Real-time PCR with reverse
transcription. In accordance with our previous results, the
expression of UCP1 was undetectable in hADMSCs and showed
a basal level in adipocytes differentiated by the white adipogenic
protocol for 14 days.38 The differentiating adipocytes were treated
with clozapine on the last 2 and 4 days or during the whole white
adipogenic differentiation process. We found that UCP1 was
expressed ﬁvefold higher as a result of clozapine administration in
each case (Figure 1). A previously described brown adipocyte
differentiation protocol,41 which turned out to induce a beige
program rather than classical brown,38 was applied as positive
control and resulted in a high expression level of the UCP1 gene;
we are referring to these cells as ‘positive control beige
adipocytes’.38,41 We also aimed to analyze the expression of a
core set of brown fat-speciﬁc genes (CIDEA,52 PGC1A53 and
ELOVL354), an indicator of the mitochondrial enrichment (CYC1),51
a beige (TBX1)10 and a classical brown adipocyte marker (ZIC1)6 in
adipocytes differentiated in the presence of clozapine. Signiﬁ-
cantly elevated expression of CIDEA, CYC1, ELOVL3, PGC1A and the
beige indicator TBX1 was found in a concentration-dependent
manner compared with the untreated white adipocytes (Figure 1
and Supplementary Figure 2). The long-term clozapine treatment
was less effective in the induction of brown and beige-related
Figure 2. Laser scanning cytometry-based population scale analysis of brown adipogenic differentiation by texture parameters and Ucp1
protein content of ex vivo-differentiated single primary adipocytes treated with clozapine. SVF-derived hADMSCs were differentiated and
treated as in Figure 1. (a) Ucp1 protein expression in one representative adipocyte donor. (b) Protein expression level of Ucp1 in the
adipocytes of three different SVF donors quantiﬁed by densitometry (as compared with untreated white adipocytes). (c) Distribution of Ucp1
in clozapine-treated human primary adipocytes. The images were collected with an iCys Research Imaging Cytometer. (d) Texture sum
variance and Ucp1 protein content of adipocytes per cell. *Po0.05, n= 3, 2000 cells each donor. (e) Dot plot ﬁgures of one representative
donor based on the identiﬁcation of browning adipocytes containing small lipid droplets and high levels of Ucp1. hADMSC, human adipose-
derived mesenchymal stem cell; SVF, stromal-vascular fraction.
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Figure 3. Induction of browning in SGBS human preadipocyte cell line as a result of clozapine treatment during white adipocyte
differentiation. Preadipocytes were differentiated for 2 weeks to white (W) or positive control beige (Be) adipocytes. Clozapine (gray bars) was
administered at 100 ng ml− 1 concentration on the last 2 and 4 days or during the whole white adipogenic differentiation process. (a) Ucp1
protein expression in one representative SGBS sample. (b) Relative mitochondrial DNA amount of SGBS adipocytes determined by qPCR in six
different samples. (c) Laser scanning cytometry-based population scale analysis of browning in one representative SGBS sample by texture
parameters and Ucp1 protein content of adipocytes. (d) Relative expression of browning marker genes in SGBS adipocytes. The experiment
was repeated six times with samples from independent passages (relative gene expression was determined by RT-qPCR, target genes were
normalized to GAPDH); *Po0.05, **Po0.01. RT-qPCR, quantitative PCR with reverse transcription; SGBS, Simpson–Golabi–Behmel syndrome.
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genes than the above-mentioned browning protocol in most of
the cases. The expression of ZIC1 remained at a low level after
clozapine administration excluding that clozapine induces classi-
cal brown adipocyte differentiation. Furthermore, clozapine
treatment moderately enhanced the expression of beta-
oxidation-related mitochondrial genes (ACOX2, CPT1A, CPT2 and
ACADM; Supplementary Figure 3a). In parallel, PRDM1655
(Figure 1), CEBPB56 (transcriptional regulators of brown and beige
adipocyte development), CEBPA, FABP4, LEPTIN and PPARG
(general adipocyte markers)57 genes expressed at the same level
in adipocytes differentiated in the presence of clozapine
compared with the untreated ones (Supplementary Figure 4).
Undifferentiated progenitors or completely differentiated white or
positive control beige adipocytes did not respond to the 12 h-long
clozapine treatment (except for the slight upregulation of TBX1 in
differentiated positive control beige adipocytes), suggesting that
the adipogenic differentiation program is required for the
aforementioned effect of clozapine (Supplementary Figure 5).
However, the inﬂuence of clozapine on the induction of browning
genes was complete in the majority of the cases even if applied
only during the last 4 or even 2 days of white adipogenic
differentiation (Figure 1). In the collected whole cell lysates of
adipocytes that were differentiated in the presence of clozapine, a
threefold elevated Ucp1 protein level was detected compared
with the untreated cells (Figures 2a and b). Thus, direct clozapine
administration during ex vivo human white adipocyte differentia-
tion induces a beige-like gene expression pattern and results in
the increased amount of Ucp1 protein.
More hADMSCs and SGBS preadipocytes differentiate into
adipocytes with morphological characteristics of browning as a
result of clozapine treatment
It has been reported that a bolus clozapine treatment at the early
stage of human adipocyte differentiation resulted in an increased
lipid content.58 We have developed a LSC-based approach to
analyze the attached adipocyte cultures at consecutive time
points.40 This slide-based image cytometry approach combines
texture analysis and detection of Ucp1 protein content in single
brown adipocytes of mixed cell populations.38 In our experiments,
up to 50% of the differentiated hADMSCs progressively accumu-
lated lipid droplets; in this respect, there was no difference
between clozapine-treated and untreated adipocytes (Figure 2c).
However, instead of the formation of large lipid droplets, we
found that the long-term clozapine administration resulted in the
occurrence of more and smaller droplets in the differentiated
adipocytes, similarly but less extensively than in the case of the
positive control beige adipocytes. The quantiﬁcation of this
phenomenon by the texture ‘sum variance’38,40,42 is shown in
Figure 2d. Signiﬁcantly elevated Ucp1 protein content was
detected simultaneously in single human adipocytes. Representa-
tive images are displayed in Figure 2c and the quantiﬁcation of
Ucp1 content in hADMSC-derived adipocytes of three different
donors is presented in Figure 2d. In Figure 2e, we plotted Ucp1
content and texture ‘sum variance’ for each differentiated
adipocyte. Adipocytes with morphological characteristics of
browning were recognized as the ones that contained small lipid
droplets and high levels of Ucp1 protein (lower right quadrant of
density plot images), in contrast to white adipocytes, which
accumulated large lipid droplets and expressed low amount of
Ucp1 (upper left quadrant of density plot images).38 The biological
variance among donors of hADMSCs was summarized in
Supplementary Table 1. Using this approach, we demonstrated
that depending on individual donors 30–40% of differentiating
single human primary adipocytes had the characteristic morpho-
logical features of browning cells as a result of clozapine
treatment.
To exclude the possible impact of heterogeneity and the lower
differentiation capacity of the primary cell model, we also
investigated the aforementioned effect of clozapine in differen-
tiating SGBS preadipocytes. SGBS cells, which are derived from a
patient with SGBS, represent a well-accepted model of human
white adipocyte differentiation.39,40,59,60 We found elevated Ucp1
protein expression (Figure 3a) and moderately increased mito-
chondrial DNA amount (Figure 3b) in the cell lysates of SGBS
adipocytes that were differentiated in the presence of clozapine
compared with the untreated white fat cells. Morphological
features of browning (Figure 3c) and a beige-like gene expression
pattern (Figure 3d) could be also detected in clozapine-treated
SGBS adipocytes. Thus, the data from both primary cells and an
adipogenic cell line corroborate that clozapine can shift the
differentiation program towards browning.
Clozapine-treated white adipocytes have increased thermogenic
competency but low sensitivity to thermogenic induction ex vivo
As a next step, we intended to investigate the functional capacity
of human primary adipocytes differentiated in the presence of
clozapine. Clozapine-treated primary adipocytes had a moderately
increased mitochondrial DNA content, to a lesser extent as
positive control beige adipocytes (Figure 4a). Figure 4b demon-
strates the OC of SVF-derived adipocytes of one representative
donor measured by an XF96 oxymeter. The basal mitochondrial
respiration of clozapine-treated white adipocytes was moderately
elevated as compared with the untreated white cells. In
accordance with our previous results,38 ex vivo-differentiated
positive control beige adipocytes had higher basal OCR than the
white adipocytes; the presence or absence of clozapine during the
differentiation did not affect the basal OCR of positive control
beige adipocytes. After the cells received a single bolus dose of
cell permeable dibutyril-cAMP mimicking adrenergic stimulation,
we found that adipocytes that were differentiated in the presence
of clozapine were less capable than the untreated cells to induce
their respiration. At the maximal level of induced respiration, the
difference in OCR demonstrated at the basal level between
clozapine-treated and untreated white adipocytes was abolished.
A similar trend was observed when cells were treated with
oligomycin that blocks the activity of ATP synthase and provides
information on proton leak respiration (Figure 4c). Considering the
fact that dibutyril-cAMP enhanced lipolysis might increase the
release of fatty acids by adipocytes, which can stimulate
respiration by artefactual mitochondrial uncoupling,44 we carried
out OC measurements including 2% BSA in the respiration buffer.
Although we observed weaker induction of OCR in response to
dibutyril-cAMP in each differentiated sample, the aforementioned
effects of clozapine on the metabolic parameters of adipocytes
could be detected in this experimental condition as well
(Supplementary Figure 6).
Recent ﬁndings revealed a substrate cycle of creatine metabo-
lism, which enhances energy expenditure in the mitochondria of
beige adipocytes. Mitochondrial creatine kinase 1 or 2 catalyzes
the conversion of creatine and utilizes ATP to create phospho-
creatine (PCr) and ADP, before Phospho1 liberates the high-
energy phosphate group from PCr.45 When adipocytes differ-
entiated in the presence of clozapine were treated with etomoxir
(O-carnitine palmitoyltransferase-1 inhibitor) or β-guanidinopro-
pionic acid (creatine analog which reduces creatine levels in the
cells), the basal and cAMP-stimulated OCRs were decreased at a
higher extent then in the case of white adipocytes. These data
demonstrate that the clozapine-induced browning cells (similar to
positive control beige adipocytes) utilize more fatty acids by beta-
oxidation than white adipocytes and further increase their energy
expenditure by activating the recently identiﬁed futile cycle of
creatine metabolism (Supplementary Figures 3b and 7).
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In parallel, we analyzed the changes in the gene expression of
the previously shown brown and beige adipocyte markers as a
result of a 4 h-long dibutyril-cAMP treatment that serves as an
ex vivo model of thermogenic induction.6 In line with the
previously described results, white adipocytes expressed UCP1
gene at a basal level. White adipocytes differentiated in the
presence of clozapine had a signiﬁcantly elevated UCP1 expres-
sion compared with the untreated cells. Positive control beige
adipocytes expressed UCP1mRNA at a higher level; in this case the
clozapine treatment did not affect UCP1 expression. A similar
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trend was observed in the case of PGC1A. The UCP1 and PGC1A
expression showed a robust (ten- and ﬁvefold, respectively)
upregulation in response to cAMP treatment of white and positive
control beige adipocytes differentiated in the absence of
clozapine. This effect of thermogenic induction was less mani-
fested in clozapine-generated beige adipocytes, with regard to
UCP1. The responsiveness of positive control beige adipocytes
differentiated in the presence of clozapine was also reduced
(Figure 4d and Supplementary Figure 8). The expression of CYC1,
CIDEA, ELOVL3, PRDM16, TBX1 and ZIC1 did not change
signiﬁcantly as a result of thermogenic induction in either
clozapine-treated or untreated adipocytes (data not shown). Of
note, beta-oxidation and creatine-driven substrate cycle was
enhanced by cAMP in a similar extent in clozapine-induced as in
positive control beige adipocytes (Supplementary Figures 3b and
7). Although the demonstrated gene expression, morphological
and functional data suggest that clozapine treatment induces the
thermogenic competency of differentiating white adipocytes,
these ‘masked’ beige cells are less capable to respond to β-
adrenergic induction of thermogenesis.
Clozapine induces browning via inhibiting 5HT-receptor-mediated
signaling
Next, we intended to learn the molecular mechanism, which can
explain the browning effect of clozapine. Although initially
introduced as a dopamine receptor antagonist in the clinical
practice, clozapine has a very diverse molecular interaction proﬁle.
It binds to different 5HT, muscarinic and histamine receptors and
antagonizes adrenergic alpha 1 and 2 or various dopamine
receptors.61–63 Fourteen different 5HT-receptor types have been
already described64 and most of them are expressed by white65,66
and brown adipocytes67,68 in rodents. In human adipocytes, the
expression of HTR1D, HTR2A, HTR3A and HTR7 were reported in
different studies.12,69
Primarily, we investigated the expression of the above-
mentioned 5HT-receptor genes. In our experiments, we found
that HTR2A was expressed at the highest level in hADMSCs and in
differentiated adipocytes. Interestingly, long-term clozapine
administration resulted in the downregulation of HTR2A gene
(Figure 5a). In addition, the HTR1D and HTR7 genes were
expressed at a lower extent. In contrast to HTR2A, their expression
was not altered in response to clozapine treatment
(Supplementary Figure 9). We found a similar expression pattern
in SGBS adipocytes, except for the undetectable expression level
of HTR7 (data not shown). The rate-limiting step of 5HT synthesis
in peripheral tissues is catalyzed by Tryptophan Hydroxylase 1
(TPH1).70 The expression of TPH1 was detectable in hADMSCs
(Figure 5a) and in SGBS preadipocytes (data not shown), and did
not change as a result of white adipocyte differentiation,
suggesting that these cells are capable of autonomously generat-
ing and releasing 5HT during adipogenesis. However, we found
decreased TPH1 expression in clozapine-induced and in positive
control beige adipocytes (Figure 5a). As a next step, exogenous
5HT was administered daily to the differentiating primary
adipocytes. We found that the upregulation of the majority of
the browning markers was signiﬁcantly attenuated when
clozapine-induced beige adipocytes were differentiated in the
presence of 5HT (Figure 5b). The expression of white and general
adipogenic markers was not changed as a result of 5HT
administration (Supplementary Figure 10). The SGBS adipocytes
differentiated in the presence of clozapine similarly responded to
the 5HT treatment (data not shown). Of note, the 5HT adminis-
tration alone did not modify the gene expression pattern of
differentiating white and positive control beige adipocytes. Our
results suggest that disturbance of 5HT production or 5HT-
mediated signaling might, at least partially, explain the browning
effect of clozapine.
DISCUSSION
The mechanisms underlying SGA-induced metabolic dysfunctions
remain barely understood.26 Only a few studies investigated the
direct effect of SGAs on differentiating human adipocytes.47,58 To
ﬁll this hiatus and to follow up our previous study where we
looked at selected adipogenic, cell cycle-related and pro-
inﬂammatory genes in SGA-treated human white adipocytes,35
in the present study we found that clozapine administration
unexpectedly resulted in the upregulation of UCP1
(Supplementary Figure 1). This prompted us to examine how
the propensity of hADMSCs and SGBS preadipocytes to differ-
entiate into heat-generating brown or beige cells is inﬂuenced by
clozapine. The administration of the drug at 20-fold higher
concentration than the upper limit of therapeutic reference range
resulted in a signiﬁcant inhibition of the differentiation of a
murine brown preadipocyte cell line.71 However, toxic effects of
the treatment for the cultured cells cannot be excluded at this
high clozapine concentration.47 On the other hand, clozapine
administration at the concentrations of therapeutic reference
range had a slight positive effect on the expression of the selected
BAT marker genes in an in vitro mouse model.71 In our
experiments, clozapine treatment resulted in signiﬁcantly elevated
expression of several brown marker genes, including the beige
indicator TBX1, in differentiating human adipocytes.
We complemented the measurements of gene expression
changes from total cell lysates with the recently described LSC
approach that helped us to speciﬁcally identify browning cells in
mixed adipocyte populations.38 When the adipocytes were
differentiated in the presence of clozapine for two weeks, the
rate of browning cells increased by approximately 1.5-fold.
Clozapine did not, however, alter the gene expression pattern of
fully differentiated white or positive control beige adipocytes. This
indicates that clozapine, most probably, induces the commitment
of mesenchymal adipocyte progenitor cells to beige adipocytes at
some point during the differentiation. The ratio of energy-
dissipating beige and energy-storing white adipocytes (which
fundamentally deﬁnes the thermogenic competency of each
individual) is determined, at least partially, during early differ-
entiation of mesenchymal progenitors into adipocyte
subtypes.14,16,17 The upregulation of the marker genes of
Figure 4. Functional analysis of ex vivo-differentiated primary adipocytes treated with clozapine. SVF-derived hADMSCs were differentiated for
2 weeks to white (W) or positive control beige (Be) adipocytes. Clozapine (red bars) was administered at 100 ng ml− 1 concentration on the last
2 and 4 days or during the whole adipogenic differentiation process. (a) Relative mitochondrial DNA amount of human adipocytes
determined by quantitative PCR in ﬁve different donors. (b) Oxygen consumption of SVF-derived adipocytes of one representative donor
measured with an XF96 oxymeter. After recording the baseline oxygen consumption, the cells received a single bolus dose of dibutyril-cAMP.
Then, stimulated oxygen consumption was recorded at every 30 min. Proton leak respiration was determined after adding oligomycin to
block ATP synthase activity. (c) Basal, cAMP-stimulated and oligomycin-inhibited oxygen consumption levels (as compared with the basal OCR
of white adipocytes) in four different SVF-derived adipocyte donors. (d) Effect of short-term cAMP treatment on the expression of UCP1 gene
in primary adipocytes. The experiment was repeated ﬁve times with SVFs from independent healthy donors (relative gene expression was
determined by RT-qPCR, target gene was normalized to GAPDH); *Po0.05, **Po0.01. hADMSC, human adipose-derived mesenchymal stem
cell; OCR, oxygen consumption rate; RT-qPCR, quantitative PCR with reverse transcription; SVF, stromal-vascular fraction.
Clozapine enhances beige potential of adipocytes
E Kristóf et al
8
Translational Psychiatry (2016), 1 – 12
Figure 5. Effect of 5HT on the induction of browning in ex vivo-differentiated primary human adipocytes treated with clozapine. SVF was
differentiated for 2 weeks to white (W) or positive control beige (Be) adipocytes. 100 ng ml− 1 clozapine (gray bars) and/or 10 μM 5HT was
administered on the last 2 and 4 days or during the whole adipogenic differentiation process. (a) Relative expression of Tryptophan
Hydroxylase 1 and HTR2A receptor in adipocytes in response to clozapine administration. (b) Relative expression of browning marker genes as
a result of clozapine and 5HT treatment. The experiment was repeated ﬁve times with SVFs from independent healthy donors (Relative gene
expression was determined by RT-qPCR, target genes were normalized to GAPDH); *Po0.05, **Po0.01. 5HT, serotonin; RT-qPCR, quantitative
PCR with reverse transcription; SVF, stromal-vascular fraction.
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browning was nearly the same when the administration of
clozapine took place only on the last 2 or 4 days of the white
adipogenic differentiation suggesting that clozapine is able to
induce this developmental shift from white to beige even at the
later stage of the ex vivo differentiation process.
Recently, two groups reported independently that peripheral
5HT reduced the beige potential and the sensitivity of brown and
beige adipocytes to thermogenic induction in a cell autonomous
manner in mice.43,70 Increased levels of peripheral 5HT72 and
polymorphisms in the TPH1 gene73 are associated with obesity.
We found that TPH1, the enzyme which catalyzes the rate-limiting
step of 5HT production outside the central nervous system, and
5HT-receptor genes are expressed in human primary and SGBS
adipocytes and by undifferentiated precursors. Furthermore,
exogenous 5HT partially abrogated the upregulation of browning
marker genes that were induced by clozapine administration. In
our experiments, out of the 5HT receptors, HTR2A was expressed
at the highest level. HTR2A initiates Gq signaling, which was
recently reported to abolish browning in mice and in human
adipocytes. In parallel, the expression of Gq protein correlated
inversely with UCP1 in WAT in vivo.74 As clozapine is able to
antagonize several 5HT receptors, with the highest afﬁnity to
HTR2A;62 the disturbance of 5HT-receptor-mediated Gq signaling
might, at least partially, explain the unexpected phenomenon
described in the present study assuming that 5HT or similarly
acting compounds are generated and released from cells during
white adipocyte differentiation.
Previously, it was found that clozapine enhances the accumula-
tion of lipids in differentiating human adipocytes which could
stand in line with its documented effect to promote obesity.58
However, we failed to detect more or larger lipid droplets in the
clozapine-treated adipocytes by LSC. These cells had smaller lipid
droplets in multilocular arrangement, more mitochondrial DNA
and expressed more Ucp1 protein than the untreated white
adipocytes. On the other hand, it should be emphasized that
beige fat cells differentiated from precursors (which process is
enhanced by clozapine administration) do not activate the
effective thermogenic program unless they are stimulated with
certain inducers, for example β-adrenergic agonists.7,10,75 The
question may arise why in vivo administration of clozapine leads
to fat gain and obesity. A similar discrepancy has been observed
with thiazolidinediones that act through the nuclear receptor
PPARG.76,77 Clinical trials implicated that rosiglitazone increases
the risk of obesity, congestive heart failure and myocardial
infarction in patients who received the drug for type 2 diabetes
mellitus,78–80 while it was capable of increasing the thermogenic
competency of WAT in mice7 and inducing browning of human
adipocytes ex vivo.41 Our data suggest that adipocytes differ-
entiated in the presence of clozapine are less sensitive to cAMP
stimulation. In line with this, altered cAMP signaling has been
reported in the brain as a result of SGA treatment in rodents81,82
and in humans.83 The observed incomplete thermogenic
response of clozapine-generated beige cells to β-adrenergic
agonist can be one of the reasons why these ‘masked’ beige
adipocytes function ineffectively also in vivo. Results from in vivo
studies focusing on the effect of SGAs on the sympathetic nervous
system have been conﬂicting.84–87 The β3-adrenergic pathway
which has a key role in the activation of thermogenesis in brown
and beige adipocytes20,88,89 has never, to our knowledge, been
investigated in this regard. Further investigations will help to
identify the ‘masked’ beige cells differentiated in response to
clozapine treatment in vivo and to ﬁnd ways to induce their
thermogenic function independently from the sympathetic
nervous system.
CONFLICT OF INTEREST
The authors declare no conﬂict of interest.
ACKNOWLEDGMENTS
This research was supported by the European Union and the State of Hungary, co-
ﬁnanced by the European Social Fund in the framework of TÁMOP-4.2.4.A/2-11/1-
2012-0001 ‘National Excellence Program’, which provided personal support to EK and
AKS, TÁMOP-4.2.2.A-11/1/KONV-2012-0023, TÁMOP-4.2.2.A-11/1/KONV-2012-0025,
GINOP-2.3.2-15-2016-00006 grant, the European Union Framework Programme 7
TRANSCOM IAPP 251506, OTKA K108308, NK105046 and the Hungarian Academy of
Sciences. We thank Dr András Mádi and Dr Máté Demény for their consultation and
for reviewing the manuscript. We acknowledge Jennifer Nagy and Szilvia Szalóki for
excellent technical assistance.
REFERENCES
1 Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197–1209.
2 Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on
cancer development and progression. Endocr Rev 2011; 32: 550–570.
3 Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldﬁne AB et al. Identiﬁ-
cation and importance of brown adipose tissue in adult humans. N Engl J Med
2009; 360: 1509–1517.
4 Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-
Kobayashi J et al. High incidence of metabolically active brown adipose tissue in
healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009; 58:
1526–1531.
5 Yoneshiro T, Aita S, Matsushita M, Kayahara T, Kameya T, Kawai Y et al. Recruited
brown adipose tissue as an antiobesity agent in humans. J Clin Invest 2013; 123:
3404–3408.
6 Cypess AM, White AP, Vernochet C, Schulz TJ, Xue R, Sass CA et al. Anatomical
localization, gene expression proﬁling and functional characterization of adult
human neck brown fat. Nat Med 2013; 19: 635–639.
7 Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J.
Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) acti-
vation of epididymally derived white adipocyte cultures reveals a population of
thermogenically competent, UCP1-containing adipocytes molecularly distinct
from classic brown adipocytes. J Biol Chem 2010; 285: 7153–7164.
8 Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J et al. Prdm16
determines the thermogenic program of subcutaneous white adipose tissue
in mice. J Clin Invest 2011; 121: 96–105.
9 Harms M, Seale P. Brown and beige fat: development, function and therapeutic
potential. Nat Med 2013; 19: 1252–1263.
10 Wu J, Boström P, Sparks LM, Ye L, Choi JH, Giang AH et al. Beige adipocytes are a
distinct type of thermogenic fat cell in mouse and human. Cell 2012; 150:
366–376.
11 Lee P, Werner CD, Kebebew E, Celi FS. Functional thermogenic beige adipogen-
esis is inducible in human neck fat. Int J Obes (Lond) 2014; 38: 170–176.
12 Shinoda K, Luijten IH, Hasegawa Y, Hong H, Sonne SB, Kim M et al. Genetic and
functional characterization of clonally derived adult human brown adipocytes.
Nat Med 2015; 21: 389–394.
13 Lee YH, Petkova AP, Mottillo EP, Granneman JG. In vivo identiﬁcation of bipo-
tential adipocyte progenitors recruited by β3-adrenoceptor activation and high-
fat feeding. Cell Metab 2012; 15: 480–491.
14 Wang QA, Tao C, Gupta RK, Scherer PE. Tracking adipogenesis during white
adipose tissue development, expansion and regeneration. Nat Med 2013; 19:
1338–1344.
15 Collins S. A heart-adipose tissue connection in the regulation of energy meta-
bolism. Nat Rev Endocrinol 2014; 10: 157–163.
16 Kajimura S, Spiegelman BM, Seale P. Brown and beige fat: physiological roles
beyond heat generation. Cell Metab 2015; 22: 546–559.
17 Lynes MD, Tseng YH. The thermogenic circuit: regulators of thermogenic com-
petency and differentiation. Genes Dis 2015; 2: 164–172.
18 Rosenwald M, Perdikari A, Rülicke T, Wolfrum C. Bi-directional interconversion of
brite and white adipocytes. Nat Cell Biol 2013; 15: 659–667.
19 Whittle AJ, López M, Vidal-Puig A. Using brown adipose tissue to treat obesity—
the central issue. Trends Mol Med 2011; 17: 405–411.
20 Cypess AM, Weiner LS, Roberts-Toler C, Franquet Elía E, Kessler SH, Kahn PA et al.
Activation of human brown adipose tissue by a β3-adrenergic receptor agonist.
Cell Metab 2015; 21: 33–38.
21 Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased
risks of cardiovascular disease. Am Heart J 2005; 150: 1115–1121.
22 De Hert M, Schreurs V, Vancampfort D, Van Winkel R. Metabolic syndrome in
people with schizophrenia: a review. World Psychiatry 2009; 8: 15–22.
23 Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M
et al. Antipsychotic-induced weight gain and metabolic abnormalities: implica-
tions for increased mortality in patients with schizophrenia. J Clin Psychiatry 2004;
65(Suppl 7): 4–18.
Clozapine enhances beige potential of adipocytes
E Kristóf et al
10
Translational Psychiatry (2016), 1 – 12
24 Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects:
a comprehensive literature review. CNS Drugs 2005; 19(Suppl 1): 1–93.
25 De Hert M, Schreurs V, Sweers K, Van Eyck D, Hanssens L, Sinko S et al. Typical and
atypical antipsychotics differentially affect long-term incidence rates of the
metabolic syndrome in ﬁrst-episode patients with schizophrenia: a retrospective
chart review. Schizophr Res 2008; 101: 295–303.
26 Gohlke JM, Dhurandhar EJ, Correll CU, Morrato EH, Newcomer JW, Remington G
et al. Recent advances in understanding and mitigating adipogenic and metabolic
effects of antipsychotic drugs. Front Psychiatry 2012; 3: 62.
27 Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH. From the cover: anti-
psychotic drug-induced weight gain mediated by histamine H1 receptor-linked
activation of hypothalamic AMP-kinase. Proc Natl Acad Sci USA 2007; 104:
3456–3459.
28 Houseknecht KL, Robertson AS, Zavadoski W, Gibbs EM, Johnson DE, Rollema H.
Acute effects of atypical antipsychotics on whole-body insulin resistance in rats:
implications for adverse metabolic effects. Neuropsychopharmacology 2007; 32:
289–297.
29 Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM et al. Metabolic
dysregulation with atypical antipsychotics occurs in the absence of underlying
disease: a placebo-controlled study of olanzapine and risperidone in dogs. Dia-
betes 2005; 54: 862–871.
30 Chintoh AF, Mann SW, Lam L, Giacca A, Fletcher P, Nobrega J et al. Insulin
resistance and secretion in vivo: effects of different antipsychotics in an
animal model. Schizophr Res 2009; 108: 127–133.
31 Davey KJ, Cotter PD, O'Sullivan O, Crispie F, Dinan TG, Cryan JF et al. Anti-
psychotics and the gut microbiome: olanzapine-induced metabolic dysfunction
is attenuated by antibiotic administration in the rat. Transl Psychiatry 2013;
3: e309.
32 Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM et al. Use of the
second-generation antipsychotic, risperidone, and secondary weight gain are
associated with an altered gut microbiota in children. Transl Psychiatry 2015; 5:
e652.
33 Victoriano M, de Beaurepaire R, Naour N, Guerre-Millo M, Quignard-Boulangé A,
Huneau JF et al. Olanzapine-induced accumulation of adipose tissue is associated
with an inﬂammatory state. Brain Res 2010; 1350: 167–175.
34 Zhang Q, He M, Deng C, Wang H, Huang XF. Effects of olanzapine on the elevation
of macrophage inﬁltration and pro-inﬂammatory cytokine expression in
female rats. J Psychopharmacol 2014; 28: 1161–1169.
35 Sárvári AK, Veréb Z, Uray IP, Fésüs L, Balajthy Z. Atypical antipsychotics induce
both proinﬂammatory and adipogenic gene expression in human adipocytes
in vitro. Biochem Biophys Res Commun 2014; 450: 1383–1389.
36 Vestri HS, Maianu L, Moellering DR, Garvey WT. Atypical antipsychotic drugs
directly impair insulin action in adipocytes: effects on glucose transport, lipo-
genesis, and antilipolysis. Neuropsychopharmacology 2007; 32: 765–772.
37 Yang LH, Chen TM, Yu ST, Chen YH. Olanzapine induces SREBP-1-related adipo-
genesis in 3T3-L1 cells. Pharmacol Res 2007; 56: 202–208.
38 Kristóf E, Doan-Xuan QM, Bai P, Bacso Z, Fésüs L. Laser-scanning cytometry can
quantify human adipocyte browning and proves effectiveness of irisin. Sci Rep
2015; 5: 12540.
39 Fischer-Posovszky P, Newell FS, Wabitsch M, Tornqvist HE. Human SGBS cells - a
unique tool for studies of human fat cell biology. Obes Facts 2008; 1: 184–189.
40 Doan-Xuan QM, Sarvari AK, Fischer-Posovszky P, Wabitsch M, Balajthy Z, Fesus L
et al. High content analysis of differentiation and cell death in human adipocytes.
Cytometry A 2013; 83: 933–943.
41 Elabd C, Chiellini C, Carmona M, Galitzky J, Cochet O, Petersen R et al. Human
multipotent adipose-derived stem cells differentiate into functional brown adi-
pocytes. Stem Cells 2009; 27: 2753–2760.
42 Abdul-Rahman O, Kristóf E, Doan-Xuan QM, Vida A, Nagy L, Horváth A et al. AMP-
activated kinase (AMPK) activation by AICAR in human white adipocytes derived
from pericardial white adipose tissue stem cells induces a partial beige-like
phenotype. PLoS One 2016; 11: e0157644.
43 Oh CM, Namkung J, Go Y, Shong KE, Kim K, Kim H et al. Regulation of systemic
energy homeostasis by serotonin in adipose tissues. Nat Commun 2015; 6: 6794.
44 Li Y, Fromme T, Schweizer S, Schöttl T, Klingenspor M. Taking control over
intracellular fatty acid levels is essential for the analysis of thermogenic function
in cultured primary brown and brite/beige adipocytes. EMBO Rep 2014; 15:
1069–1076.
45 Kazak L, Chouchani ET, Jedrychowski MP, Erickson BK, Shinoda K, Cohen P et al. A
creatine-driven substrate cycle enhances energy expenditure and thermogenesis
in beige fat. Cell 2015; 163: 643–655.
46 Tews D, Schwar V, Scheithauer M, Weber T, Fromme T, Klingenspor M et al.
Comparative gene array analysis of progenitor cells from human paired deep
neck and subcutaneous adipose tissue. Mol Cell Endocrinol 2014; 395: 41–50.
47 Sertié AL, Suzuki AM, Sertié RA, Andreotti S, Lima FB, Passos-Bueno MR et al.
Effects of antipsychotics with different weight gain liabilities on human in vitro
models of adipose tissue differentiation and metabolism. Prog Neuropsycho-
pharmacol Biol Psychiatry 2011; 35: 1884–1890.
48 Coryell W, Miller DD, Perry PJ. Haloperidol plasma levels and dose optimization.
Am J Psychiatry 1998; 155: 48–53.
49 Broich K, Heinrich S, Marneros A. Acute clozapine overdose: plasma concentration
and outcome. Pharmacopsychiatry 1998; 31: 149–151.
50 Bergemann N, Frick A, Parzer P, Kopitz J. Olanzapine plasma concentration,
average daily dose, and interaction with co-medication in schizophrenic patients.
Pharmacopsychiatry 2004; 37: 63–68.
51 Cannon B, Nedergaard J. Brown adipose tissue: function and physiological sig-
niﬁcance. Physiol Rev 2004; 84: 277–359.
52 Hallberg M, Morganstein DL, Kiskinis E, Shah K, Kralli A, Dilworth SM et al.
A functional interaction between RIP140 and PGC-1alpha regulates the
expression of the lipid droplet protein CIDEA. Mol Cell Biol 2008; 28:
6785–6795.
53 Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-
inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell
1998; 92: 829–839.
54 Tvrdik P, Asadi A, Kozak LP, Nedergaard J, Cannon B, Jacobsson A. Cig30, a mouse
member of a novel membrane protein gene family, is involved in the recruitment
of brown adipose tissue. J Biol Chem 1997; 272: 31738–31746.
55 Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S et al. PRDM16 controls a
brown fat/skeletal muscle switch. Nature 2008; 454: 961–967.
56 Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP et al. Initiation of
myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex.
Nature 2009; 460: 1154–1158.
57 Lowe CE, O'Rahilly S, Rochford JJ. Adipogenesis at a glance. J Cell Sci 2011; 124:
2681–2686.
58 Hemmrich K, Gummersbach C, Pallua N, Luckhaus C, Fehsel K. Clozapine
enhances differentiation of adipocyte progenitor cells. Mol Psychiatry 2006; 11:
980–981.
59 Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C et al. FTO
obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015;
373: 895–907.
60 Wabitsch M, Brenner RE, Melzner I, Braun M, Möller P, Heinze E et al. Character-
ization of a human preadipocyte cell strain with high capacity for adipose
differentiation. Int J Obes Relat Metab Disord 2001; 25: 8–15.
61 Naheed M, Green B. Focus on clozapine. Curr Med Res Opin 2001; 17: 223–229.
62 Correll CU. From receptor pharmacology to improved outcomes: individualising
the selection, dosing, and switching of antipsychotics. Eur Psychiatry 2010; 25
(Suppl 2): S12–S21.
63 Taly A. Novel approaches to drug design for the treatment of schizophrenia.
Expert Opin Drug Discov 2013; 8: 1285–1296.
64 Nichols DE, Nichols CD. Serotonin receptors. Chem Rev 2008; 108: 1614–1641.
65 Kinoshita M, Ono K, Horie T, Nagao K, Nishi H, Kuwabara Y et al. Regulation of
adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and
5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol
Endocrinol 2010; 24: 1978–1987.
66 Stunes AK, Reseland JE, Hauso O, Kidd M, Tømmerås K, Waldum HL et al. Adi-
pocytes express a functional system for serotonin synthesis, reuptake and
receptor activation. Diabetes Obes Metab 2011; 13: 551–558.
67 Uldry M, Yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM. Complementary
action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat dif-
ferentiation. Cell Metab 2006; 3: 333–341.
68 Timmons JA, Wennmalm K, Larsson O, Walden TB, Lassmann T, Petrovic N et al.
Myogenic gene expression signature establishes that brown and white adipo-
cytes originate from distinct cell lineages. Proc Natl Acad Sci USA 2007; 104:
4401–4406.
69 Tchkonia T, Lenburg M, Thomou T, Giorgadze N, Frampton G, Pirtskhalava T et al.
Identiﬁcation of depot-speciﬁc human fat cell progenitors through distinct
expression proﬁles and developmental gene patterns. Am J Physiol Endocrinol
Metab 2007; 292: E298–E307.
70 Crane JD, Palanivel R, Mottillo EP, Bujak AL, Wang H, Ford RJ et al. Inhibiting
peripheral serotonin synthesis reduces obesity and metabolic dysfunc-
tion by promoting brown adipose tissue thermogenesis. Nat Med 2015; 21:
166–172.
71 Oh JE, Cho YM, Kwak SN, Kim JH, Lee KW, Jung H et al. Inhibition of mouse brown
adipocyte differentiation by second-generation antipsychotics. Exp Mol Med 2012;
44: 545–553.
72 Kim HJ, Kim JH, Noh S, Hur HJ, Sung MJ, Hwang JT et al. Metabolomic analysis of
livers and serum from high-fat diet induced obese mice. J Proteome Res 2011; 10:
722–731.
73 Kwak SH, Park BL, Kim H, German MS, Go MJ, Jung HS et al. Association of
variations in TPH1 and HTR2B with gestational weight gain and measures of
obesity. Obesity (Silver Spring) 2012; 20: 233–238.
Clozapine enhances beige potential of adipocytes
E Kristóf et al
11
Translational Psychiatry (2016), 1 – 12
74 Klepac K, Kilić A, Gnad T, Brown LM, Herrmann B, Wilderman A et al. The Gq
signalling pathway inhibits brown and beige adipose tissue. Nat Commun 2016; 7:
10895.
75 Klaus S, Ely M, Encke D, Heldmaier G. Functional assessment of white and brown
adipocyte development and energy metabolism in cell culture. Dissociation of
terminal differentiation and thermogenesis in brown adipocytes. J Cell Sci 1995;
108: 3171–3180.
76 Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M et al. PPARγ signaling
and metabolism: the good, the bad and the future. Nat Med 2013; 19: 557–566.
77 Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell 2014;
156: 20–44.
78 Kung J, Henry RR. Thiazolidinedione safety. Expert Opin Drug Saf 2012; 11:
565–579.
79 Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and
death from cardiovascular causes. N Engl J Med 2007; 356: 2457–2471.
80 Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley C, Worrall C et al. Risk
of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare
patients treated with rosiglitazone or pioglitazone. JAMA 2010; 304: 411–418.
81 Dwivedi Y, Rizavi HS, Pandey GN. Differential effects of haloperidol and clozapine
on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein
expression of selective regulatory and catalytic subunit isoforms of PKA in
rat brain. J Pharmacol Exp Ther 2002; 301: 197–209.
82 Turalba AV, Leite-Morris KA, Kaplan GB. Antipsychotics regulate cyclic AMP-
dependent protein kinase and phosphorylated cyclic AMP response element-
binding protein in striatal and cortical brain regions in mice. Neurosci Lett 2004;
357: 53–57.
83 Marazziti D, Baroni S, Palego L, Betti L, Giannaccini G, Castagna M et al. Clozapine
effects on adenylyl cyclase activity and serotonin type 1 A receptors in human
brain post-mortem. J Psychopharmacol 2014; 28: 320–328.
84 Elman I, Goldstein DS, Green AI, Eisenhofer G, Folio CJ, Holmes CS et al. Effects of
risperidone on the peripheral noradrenegic system in patients with schizophrenia:
a comparison with clozapine and placebo. Neuropsychopharmacology 2002; 27:
293–300.
85 Monda M, Viggiano A, Viggiano A, Fuccio F, De Luca V. Clozapine blocks sym-
pathetic and thermogenic reactions induced by orexin A in rat. Physiol Res 2004;
53: 507–513.
86 Savoy YE, Ashton MA, Miller MW, Nedza FM, Spracklin DK, Hawthorn MH et al.
Differential effects of various typical and atypical antipsychotics on plasma glu-
cose and insulin levels in the mouse: evidence for the involvement of sympathetic
regulation. Schizophr Bull 2010; 36: 410–418.
87 Blessing WW, Seaman B, Pedersen NP, Ootsuka Y. Clozapine reverses hyper-
thermia and sympathetically mediated cutaneous vasoconstriction induced by
3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. J Neurosci
2003; 23: 6385–6391.
88 Inokuma K, Okamatsu-Ogura Y, Omachi A, Matsushita Y, Kimura K, Yamashita H
et al. Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-
adrenergic stimulation. Am J Physiol Endocrinol Metab 2006; 290: E1014–E1021.
89 Mund RA, Frishman WH. Brown adipose tissue thermogenesis: β3-adreno-
receptors as a potential target for the treatment of obesity in humans. Cardiol Rev
2013; 21: 265–269.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
© The Author(s) 2016
Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)
Clozapine enhances beige potential of adipocytes
E Kristóf et al
12
Translational Psychiatry (2016), 1 – 12
